MFDS — authorised 28 June 2012
- Marketing authorisation holder: APGDI
- Status: likely_approved
🇰🇷 Myrbetriq in South Korea
MFDS authorised Myrbetriq on 28 June 2012
Marketing authorisation
Myrbetriq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Urology approved in South Korea
Frequently asked questions
Is Myrbetriq approved in South Korea?
Yes. MFDS authorised it on 28 June 2012.
Who is the marketing authorisation holder for Myrbetriq in South Korea?
APGDI holds the South Korean marketing authorisation.